Insider Trading Activity Reata Pharmaceuticals Inc (NASDAQ:RETA) – Major Shareholder Bought 17,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Reata Pharmaceuticals Inc (NASDAQ:RETA)

James W Traweek Jr , Major Shareholder of Reata Pharmaceuticals Inc (NASDAQ:RETA) reportedly Bought 17,000 shares of the company’s stock at an average price of 28.47 for a total transaction amount of $483,990.00 SEC Form

Insider Trading History For Reata Pharmaceuticals Inc (NASDAQ:RETA)

  • On 6/1/2016 R Kent Mcgaughy Jr, Director, bought 251,553 with an average share price of $12.70 per share and the total transaction amounting to $3,194,723.10.View SEC Filing
  • On 6/1/2016 James Warren Huff, Insider, bought 114,000 with an average share price of $11.00 per share and the total transaction amounting to $1,254,000.00.View SEC Filing
  • On 6/1/2016 A/S Novo, Major Shareholder, bought 750,000 with an average share price of $11.00 per share and the total transaction amounting to $8,250,000.00.View SEC Filing
  • On 6/7/2016 R Kent Mcgaughy Jr, Director, bought 24,220 with an average share price of $17.57 per share and the total transaction amounting to $425,545.40.View SEC Filing
  • On 6/27/2016 Cpmg Inc, Director, bought 73,403 with an average share price of $19.26 per share and the total transaction amounting to $1,413,741.78.View SEC Filing
  • On 6/30/2016 James W Traweek Jr, Major Shareholder, bought 164,600 with an average share price of $19.78 per share and the total transaction amounting to $3,255,788.00.View SEC Filing
  • On 8/16/2016 Colin John Meyer, Insider, bought 7,000 with an average share price of $16.26 per share and the total transaction amounting to $113,820.00.View SEC Filing

    • Analyst Ratings History For Reata Pharmaceuticals Inc (NASDAQ:RETA)

    • On 7/24/2017 Piper Jaffray Companies Boost Price Target of rating Buy with a price target of $53.00 to $60.00
    • On 7/25/2017 Stifel Nicolaus Reiterated Rating Buy with a price target of $38.00 to $50.00
    • On 7/26/2017 Ladenburg Thalmann Financial Services Reiterated Rating Buy with a price target of $55.00 to $61.00
    • On 8/23/2017 Citigroup Reiterated Rating Buy with a price target of $87.00 to $78.00
    • On 9/13/2017 Leerink Swann Initiated Coverage of rating Outperform to Outperform with a price target of $43.00
    • On 10/6/2017 Jefferies Group Reiterated Rating Buy with a price target of $44.00
    • On 10/24/2017 Robert W. Baird Reiterated Rating Buy with a price target of $47.00

    Recent Trading Activity for Reata Pharmaceuticals Inc (NASDAQ:RETA)
    Shares of Reata Pharmaceuticals Inc closed the previous trading session at 28.32 up +1.36 5.04% with 29.280000686645508 shares trading hands.